Portola Pharmaceuticals Inc. (PTLA) Soars 14.22% on December 31

Equities Staff  |

Portola Pharmaceuticals Inc. (PTLA) had a good day on the market for Monday December 31 as shares jumped 14.22% to close at $19.52. About 4.1 million shares traded hands on 21,720 trades for the day, compared with an average daily volume of n/a shares out of a total float of 66.43 million. After opening the trading day at $17.18, shares of Portola Pharmaceuticals Inc. stayed within a range of $20.12 to $16.52.

With today's gains, Portola Pharmaceuticals Inc. now has a market cap of $1.3 billion. Shares of Portola Pharmaceuticals Inc. have been trading within a range of $55.48 and $14.81 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Portola Pharmaceuticals is a biotechnology company focused on developing and commercializing novel therapeutics. The company focuses on areas of thrombosis, other hematologic disorders, and inflammation for patients who have limited or no approved treatment options. Portola focuses on biomarker or genetic approaches to clinical development that it believes will increase the probability of clinical, regulatory, and commercial success of first-in-class therapies. The company also uses collaborative agreements.

Portola Pharmaceuticals Inc. is based out of South San Francisco, CA and has some 252 employees. Its CEO is Scott Garland.

For a complete fundamental analysis of Portola Pharmaceuticals Inc., check out Equities.com’s Stock Valuation Analysis report for PTLA.

Still paying commissions on stock trades? Equities.com now offers 100% commission free stock trading and flat-fee options trading for $89.95/month! Get started today by https://www.equities.com/trading

Portola Pharmaceuticals Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on Portola Pharmaceuticals Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: PTLA’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit Equities.com’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.



DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
GOOG

     
XOM

     
BRK.A

     
FB

     
JNJ

     
WFC

     
T

     
NFLX

     
TSLA

     
V

     
UNH

     
PG

     

World Economic Forum at Davos 2019 - Joseph Weinberg CEO PayCase, Chairman Shyft

Matt Bird sits down with Joseph Weinberg CEO PayCase, Chairman Shyft at the World Economic Forum at Davos 2019